International Stem Cell (ISCO) Change in Cash (2010 - 2025)
International Stem Cell (ISCO) posted quarterly Change in Cash of $27000.0 for Q4 2025, up 135.06% year-over-year from $11486.2 in Q4 2024, and down 41.3% quarter-over-quarter from $46000.0 in Q3 2025.
International Stem Cell (ISCO) Change in Cash (2010 - 2025) Analysis & Trends
International Stem Cell (ISCO) has reported Change in Cash for 16 consecutive years, with $27000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Change in Cash rose 135.06% year-over-year to $27000.0; the TTM figure through Dec 2025 stood at -$237000.0 (up 33.8% YoY), while the FY2025 annual figure was -$237000.0, up 33.8% from the prior year.
- Change in Cash fell to $27000.0 in Q4 2025 per ISCO's latest filing, from $46000.0 in the prior quarter.
- Across five years, Change in Cash topped out at $439000.0 in Q2 2023 and bottomed at -$532000.0 in Q2 2025.
- Historically, Change in Cash has averaged $15200.0 across 5 years, with a median of $47000.0 in 2023.
- On a YoY basis, Change in Cash climbed as much as 209.9% in 2025 and fell as far as 454.17% in 2025.
- International Stem Cell's Change in Cash stood at -$334000.0 in 2021, then surged by 122.75% to $76000.0 in 2022, then soared by 107.89% to $158000.0 in 2023, then sank by 148.73% to -$77000.0 in 2024, then soared by 135.06% to $27000.0 in 2025.
- Business Quant data shows ISCO's Change in Cash at $27000.0 in Q4 2025, $46000.0 in Q3 2025, and -$532000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | International Stem Cell | 3.76 Mn | 2.67 Mn | 1.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 27,000.00 |
| Sep 30, 2025 | 46,000.00 |
| Jun 30, 2025 | -532,000.00 |
| Mar 31, 2025 | 222,000.00 |
| Dec 31, 2024 | -77,000.00 |
| Sep 30, 2024 | 17,000.00 |
| Jun 30, 2024 | -96,000.00 |
| Mar 31, 2024 | -202,000.00 |
| Dec 31, 2023 | 158,000.00 |
| Sep 30, 2023 | 48,000.00 |
| Jun 30, 2023 | 439,000.00 |
| Mar 31, 2023 | 201,000.00 |
| Dec 31, 2022 | 76,000.00 |
| Sep 30, 2022 | 80,000.00 |
| Jun 30, 2022 | 188,000.00 |
| Mar 31, 2022 | 227,000.00 |
| Dec 31, 2021 | -334,000.00 |
| Sep 30, 2021 | -245,000.00 |
| Jun 30, 2021 | -367,000.00 |
| Mar 31, 2021 | 428,000.00 |